[Immunosuppressive agents--advances of the developmental studies and the mode of action].
Ochiai
T
T
Department of Surgery, School of Medicine, Chiba University.
Isono
K
K
Gunji
Y
Y
Nagata
M
M
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D003524:Cyclosporins / Q000494:pharmacology; D006085:Graft Survival / Q000187:drug effects*; D006146:Guanidines / Q000494:pharmacology; D006801:Humans; D007166:Immunosuppressive Agents / Q000737:chemistry / Q000145:classification / Q000494:pharmacology*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D011090:Polyenes / Q000494:pharmacology; D020123:Sirolimus; D016559:Tacrolimus; D014180:Transplantation
D000900:Anti-Bacterial Agents; D003524:Cyclosporins; D006146:Guanidines; D007166:Immunosuppressive Agents; D011090:Polyenes; D009173:Mycophenolic Acid; C037258:gusperimus; D020123:Sirolimus; D016559:Tacrolimus